Claudio G. Brunstein
Hematology Oncology | Hematology | Oncology
10201 Carnegie Avenue
Cleveland, OH 44106
Cleveland, OH 44106
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 169 publications
Step-Specific Activation Timelines for Cellular Therapy Clinical Trials: A Decade of Regulatory Improvement and Persistent Financial Bottlenecks.
Journal: Transplantation and cellular therapy
Published: April 20, 2026
Neighborhood Socioeconomic Disadvantage and Distance From Treatment Center do not Impact Survival Outcomes of Patients With Non-Hodgkin Lymphoma and Multiple Myeloma Treated With CAR T-Cell Therapies.
Journal: Transplantation and cellular therapy
Published: April 17, 2026
Paramagnetic rim lesions on 7T MRI after autologous hematopoietic cell transplantation.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: March 13, 2026
Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 18, 2025
Health Care, Physics, and Finance: The Complex Equation of Outpatient CAR T-Cell Therapy.
Journal: JCO oncology practice
Published: May 01, 2025
Infections in steroid-refractory chronic graft versus host disease patients treated with ruxolitinib, ibrutinib, or belumosudil.
Journal: Bone marrow transplantation
Published: April 16, 2025
Myeloablative and Reduced Intensity Allogeneic Transplant in Patients with Myeloproliferative Neoplasms.
Journal: Hematology/oncology and stem cell therapy
Published: March 04, 2025
Impact of Obesity on GVHD in Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Hematologic Malignancies.
Journal: Transplantation and cellular therapy
Published: November 11, 2024
Influence of pre-transplant estimated glomerular filtration rate (eGFR) on clinical outcomes after allogeneic hematopoietic cell transplantation.
Journal: Bone marrow transplantation
Published: November 06, 2024
Donor Type Does Not Impact Late Graft Failure Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis.
Journal: Transplantation and cellular therapy
Published: September 26, 2024
Last Updated: 09/26/2026